Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.
scientific article published on 29 March 2017
Author/s
author: Peter Johnson, Emanuele Zucca, Umberto Vitolo, Pierre Zachee, Corinne Haioun, Franco Cavalli, Graziella Pinotti, Catherine Thieblemont, Gilles Salles, Elías Campo, Annarita Conconi, Reda Bouabdallah, Catherine Sebban, Franck Morschhauser, Maurizio Martelli, Hervé Tilly, Caterina Stelitano, Armando López-Guillermo
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.